Evotec Receives Milestones in its Neurodegeneration Collaboration with BMS

Shots: Evotec has received $6M as milestones under its iPSC-based neuroscience alliance with BMS. The milestones follow BMS’ decision to add another drug discovery project to the partnership’s portfolio In 2016, the companies collaborated to identify disease-modifying treatments for neurodegenerative diseases The partnership b/w both the companies has found several access points into neurodegenerative diseases …

Evotec Receives Milestones in its Neurodegeneration Collaboration with BMS Read More »